Join our mini-symposium on Cancer Radiotheranostics on January 30, 2024, including the PhD defence of Karuna Adhikari. (more…)
We are excited to announce an open vacancy for a full-time (100%) postdoctoral researcher in the field of radiopharmacy/radiochemistry! (more…)
Improved FAP-radiotheranostics for personalized cancer treatment Cancer-associated fibroblasts (CAFs) are a group of tumor stromal cells typically associated with cancer growth and metastasis. These CAFs show high expression of the... read more →
Louis Lauwerys a PhD student from CREANT has won a poster award at the European Molecular Imaging Meeting (EMIM) in Salzburg (Austria) for his work on the design and evaluation... read more →
On November 3, 2022, Jonatan Dewulf, a member of CREANT, has defended his PhD thesis entitled: 'Elucidating the tumor microenvironment: immuno-PET imaging of RANKL and CD70' Congratulations Jonatan!
Our team has developed a novel immuno-PET imaging tool that can help tailoring cancer therapies. Check out our latest publication.
The European medical isotope programme – PRISMAP – has launched. This consortium aims to fast-track nuclear medicine research. Check the website!
The website for the Center for Radiopharmaceuticals Antwerp (CREANT) was just launched. More news coming soon.